Evidence map›Paper›PMID 35281516›Full record

ArticleJournal of oncology2022

Solasonine Induces Apoptosis and Inhibits Proliferation of Bladder Cancer Cells by Suppressing NRP1 Expression.

Yang Dong, Lin Hao, Zhen-Duo Shi, Kun Fang, Hui Yu, Guang-Hui Zang, Tao Fan, Cong-Hui Han

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Anticancer activity of glycoalkaloids fromFrontiers in pharmacology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yang DongDepartment of Urology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China.
Lin HaoDepartment of Urology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China.
Zhen-Duo ShiDepartment of Urology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China.
Kun FangDepartment of Nephrology, The Third Affiliated Hospital of Shandong First Medical University, Jinan, Shandong Province, China.
Hui YuDepartment of Urology, Yantai Hospital of Traditional Chinese Medicine, Yantai, Shandong Province, China.
Guang-Hui ZangDepartment of Urology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China.
Tao FanDepartment of Urology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China.
Cong-Hui HanDepartment of Urology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China.ORCID https://orcid.org/0000-0001-6227-630X
Xuzhou Medical College · CNShandong First Medical University · CNYantaishan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solasonine, a steroidal alkaloid extracted from

Identifiers

PMID35281516
PMCPMC8906937
OpenAlexW4214914240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.